Tags

asthma drug approval

Kelun-Biotech and Harbour BioMed win NMPA approval for asthma drug

Kelun-Biotech and Harbour BioMed win NMPA approval for asthma drug

July 16, 2026 | 11:16
Kelun-Biotech and Harbour BioMed, both Hong Kong-listed biopharmaceutical companies, announced China's National Medical Products Administration approved their investigational new drug application for SKB575/HBM7575 to treat asthma.

Latest News

Dragon Capital: Vietnam has 3–5 years to cut bank reliance

Dragon Capital: Vietnam has 3–5 years to cut bank reliance

IBM launches Power Autonomous Operations AI agent

IBM launches Power Autonomous Operations AI agent

Telix doses first patients in OPTIMAL-e prostate cancer trial

Telix doses first patients in OPTIMAL-e prostate cancer trial

Kelun-Biotech and Harbour BioMed win NMPA approval for asthma drug

Kelun-Biotech and Harbour BioMed win NMPA approval for asthma drug

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Ngo Chi Tung, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2026 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society Swing for the Kids CSR
World News
virs-publications-vir
timeout-vn
ptbv2020